Please login to the form below

Not currently logged in
Email:
Password:

UK department of health

This page shows the latest UK department of health news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Dementia Fund hits $350m mark, hard Brexit could cost £100bn in trade and troublesome results for Pfizer’s Ibrance

Daily Brief: Dementia Fund hits $350m mark, hard Brexit could cost £100bn in trade and troublesome results for Pfizer’s Ibrance

It was formed through the collaboration of leading pharma companies - Biogen, Eli Lilly and Company, GSK, Johnson &Johnson, Otsuka (Astex), Pfizer and Takeda -, the UK Department of Health and Social Care ... The latter is of paramount importance to the

Latest news

More from news
Approximately 2 fully matching, plus 93 partially matching documents found.

Latest Intelligence

  • Changes to look out for in Medical Devices Regulations Changes to look out for in Medical Devices Regulations

    The UK Department of Health undertook a review into the scandal and the actions of the Medicines and Healthcare Regulatory Agency (MHRA), ultimately concluding that PIP deliberately concealed its use of ... non-approved filler material, and that there

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    NHS England will play a big role in talks to renew the Pharmaceutical Price Regulation Scheme (PPRS) - formerly a simple two-way conversation between the Department of Health (representing all the ... The size of this budget increase - and the strings

  • Brexit: Implications for the pharma industry Brexit: Implications for the pharma industry

    The EMA. The EMA is currently based in London. In February 2017, the health secretary, Jeremy Hunt acknowledged the EMA would leave the UK as part of Brexit. ... There is concern that patients could face delays in accessing new medicines should the UK

  • Seeking improvements

    strategy. In policy terms, 2009 was a significant year for people with rheumatoid arthritis (RA) living in the UK. ... The Department of Health's 18-week Commissioning Pathway for Inflammatory Arthritis documented for the first time the services and care

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • New health ministers and re-appointments after reshuffle New health ministers and re-appointments after reshuffle

    Jeremy Hunt and George Freeman have kept their health and life science roles but there are new faces for pharma after the UK government reshuffles the Department of Health after ... The full list of ministers now working within the Department of Health

  • UK names guardian for national health data UK names guardian for national health data

    Dame Fiona Caldicott is “people’s champion” for medical information. The UK's Department of Health (DH) has appointed Dame Fiona Caldicott as the nation's guardian for health and care ... Dame Fiona has significant experience in UK healthcare, with

  • New chair of the British Pharmacopoeia Commission New chair of the British Pharmacopoeia Commission

    UCL's Kevin Taylor to lead body to oversee pharmaceutical standards. The UK's Department of Health (DH) has named Prof Kevin Taylor as the new chair of the British Pharmacopoeia ... drugs. He is head of the department of pharmaceutics at the University

  • Changes at several UK health bodies Changes at several UK health bodies

    Round-up of recent Department of Health appointments. The Department of Health for England and Wales has announced appointments to several of its public bodies and committees. ... He has previous experience as head of mergers and acquisitions at the NHS

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Forecasting in Forgotten Markets

    One of these industry events was focused on the recent developments in Dementia () , hosted by Eli Lilly in their UK offices. ... This charitable fund represents collaboration between the Department of Health, Alzheimer’s Research UK () and a number of

  • Can rare diseases be a viable option for the pharma industry?

    Department of Health &Human Services, Office of Inspector General, The Orphan Drug Act – Implementation and Impact, May 2001. ... 36 Biotech / Pharmaceutical companies and 37 patient advocacy groups interviewed by Department of Health &Human Services,

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics